Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

ANVS US Equity

Annovis Bio, Inc.Health Care · Pharmaceutical Preparations · CIK 1477845 · FY ends Dec 31
$1.85
+0.05 (+2.78%)
USD · as of 2026-08-19 · marketstack
2 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1413GSchedule 13G filed — ≥5% beneficial owner (passive) · by HIGHBRIDGE CAPITAL MANAGEMENT LLCsec.gov ↗
2026-07-2913GSchedule 13G filed — ≥5% beneficial owner (passive) · by Empery Asset Management, LPsec.gov ↗
2026-07-098-K 8.01Other eventssec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-09

Every row is a filed document, checked against its EDGAR index.